This course will enable the students to –
Course Outcomes (COs):
Course |
Learning outcome (at course level) |
Learning and teaching strategies |
Assessment Strategies |
|
---|---|---|---|---|
Paper Code |
Paper Title |
|||
MBL 321
|
Medical Microbiology
|
Upon completion of the course students will be able to CO 58: Evaluate basic principles and application relevance of clinical disease. CO 59: Identify and Evaluate methods used to identify infectious agents CO 60: Diagnose common infectious diseases from the clinical presentation and describe the epidemiology of infectious agents CO 61: Assess treatment strategies |
Approach in teaching: Interactive Lectures, Discussion, Tutorials, Reading assignments, Demonstration, Team teaching Learning activities for the students: Self learning assignments, Effective questions, Giving tasks |
Class test, Semester end examinations, Quiz, Solving problems in tutorials, Assignments, Presentation |
Entry of pathogens into the host; colonization and mechanism of bacterial adhesion establishment, spreading, tissue damage and anti-phagocytic factors; factors predisposing to infections, types of toxins and their structure; mode of action.
Animal viruses Epidemiology, life cycle, pathogenicity, diagnosis, prevention and treatment of RNA viruses- Picorna virus family- Poliomyelitis, Orthomyxoviruses- influenza, Paramyxoviruses- Mumps, Measles, HIV; DNA viruses; Pox virus- Variola and Vaccina, Herpes virus- Varicella Zoster virus, Hepatitis viruses, Arthropod borne (arbo) Viral disease- Dengu
Mode of action of penicillin, cephalosporin, quinonoles, Sulfa drugs, streptomycin, tetracycline and other broad spectrum antibiotics, antibiotic resistance in bacteria. Antifungal drugs, antiviral drugs.
Laboratory control of antimicrobial therapy; various methods of drug susceptibility testing. Brief account on available vaccines and Schedules; passive prophylactic measures. Viral vaccines (conventional vaccines, genetic recombinant vaccines used in national immunization programmes with example, newer generation vaccines including DNA vaccines with examples)